NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Status:
Recruiting
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
This research study involves studying a device as a possible treatment for metastatic
melanoma in the brain. The purpose of this study is to obtain information on the safety and
effectiveness of the study device, NovoTTF-200A, in melanoma participants with brain
metastases when it is combined with Pembrolizumab.
The name of the study device involved in this study is:
-- NovoTTF-200A
The name of the drug used in this study is:
-- Pembrolizumab